Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria.
about
Demographics, guidelines, and clinical experience in severe community-acquired pneumoniaSevere community-acquired pneumonia: timely management measures in the first 24 hoursInfluenza A 2009 (H1N1) virus in admitted and critically ill patients.Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort.Long-term prognosis in community-acquired pneumonia.Defining and predicting severe community-acquired pneumonia.Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality.Time to intubation is associated with outcome in patients with community-acquired pneumonia.Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia.A simple score to predict the outcome of severe malaria in adults.Critical care medicine in AJRCCM 2002.Tuberculosis, lung infections, interstitial lung disease, and journalology in AJRCCM 2002.Severity assessment of lower respiratory tract infection in Malawi: derivation of a novel index (SWAT-Bp) which outperforms CRB-65.Disability among elderly survivors of mechanical ventilation.Defining severe pneumonia.Causes of non-adherence to therapeutic guidelines in severe community-acquired pneumoniaValidation of predictive rules and indices of severity for community acquired pneumoniaMultinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational studyVariants in the Mannose-binding Lectin Gene MBL2 do not Associate With Sepsis Susceptibility or Survival in a Large European CohortEarly cardiac arrest in patients hospitalized with pneumonia: a report from the American Heart Association's Get With The Guidelines-Resuscitation Program.A Biomathematical Model of Pneumococcal Lung Infection and Antibiotic Treatment in MiceProspective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong.A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumoniaHypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia.Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumoniaImproving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission.Mortality of community-acquired pneumonia in Korea: assessed with the pneumonia severity index and the CURB-65 score.PROGRESS - prospective observational study on hospitalized community acquired pneumoniaRisk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule.Novel targets in the management of pneumonia.Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia.Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia.Macrolide use in the treatment of critically ill patients with pneumonia: Incidence, correlates, timing and outcomes.Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens.Management of community-acquired pneumonia: a review and update.Towards a sensible comprehension of severe community-acquired pneumonia.Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis.Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers.Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.
P2860
Q21195015-2A269930-D4CD-4B56-A11D-B41312E0C629Q26738591-D0BA7830-1E2B-4E28-A558-B15DE15270A3Q30399419-3AD88DB7-C7A2-45DB-B0FD-B5AEC98E61BBQ33752549-9B03932A-6ECB-41FB-BDDB-653EB3721A3EQ33790638-6E50243D-76A3-42F6-8F13-6922C5139BF9Q33872274-56DBA05B-3EB1-48D4-9707-9CA8CF9FFBBDQ34492540-D9F9D19A-2B59-4AFF-B431-00C5164C5234Q34999389-AB6C7589-9649-4F0A-B96C-06ED16BCD0FDQ35008394-F5FE26E9-FC6A-41FF-8B0C-6D413E769C6DQ35036422-23730419-0362-4440-846E-7D9826BB634DQ35055439-422A71B7-8503-4392-A74F-84511413F7F8Q35055456-60C072AB-1AEB-4B6E-B3BC-870E64321022Q35064123-0E2D021E-53DD-436B-A4E3-B5BF624A597BQ35173494-24A7F8B0-641F-48D0-860B-569D733536FCQ35184605-5A26E602-DDAF-42D3-9EFA-90A5533C9758Q35414598-AC8AD4C2-853F-476C-94AC-6BB6701BE2FAQ35536679-A4B62E31-AD25-462E-955A-53870DFB8CBEQ35559416-4C3DEEB9-1955-45E7-A35E-15BF8F68D444Q35933794-FC542FDC-D587-4A2B-9830-762E4F93E1AAQ36009084-36822093-C5BC-4C72-AA6E-9526763027AFQ36022465-47E010C9-7619-435B-92FF-70D7A91CB871Q36166328-93B89E72-40C1-47F4-92D7-6C29F1AA7FD1Q36203036-5AB2A4FA-89D2-4850-AC80-4A578F888220Q36388035-C763AF33-D306-4931-A87E-E90111E7390FQ36531162-CBA8856F-2552-407E-A1E9-65EEF0189E8EQ36767156-CEDD7618-2B90-4E6D-8737-0A5E9957B612Q37147304-4346C39B-B0CC-4EA1-8022-9C907853644DQ37182263-C2A15DDF-C114-4CAE-BE5B-0A0F2702EAC2Q37210137-0C584F2F-E8EF-4546-AF16-825D5AD961D4Q37362652-17DEB315-2325-44DC-88D6-6605F3D61AC5Q37416933-CEE25957-8B0C-4104-826E-06B64CE436D8Q37440972-0F1151AD-A478-4090-B12D-315AF2C88878Q37525663-1C50EA95-5918-4DCE-AAD5-07F1A6A0650CQ37661000-AA157215-7586-46A9-9255-C43889B83D6DQ37799174-5C067138-EA3A-44A9-ACD6-932D6C93E019Q37809786-CAF001CE-6E8C-4021-ADF6-581A00315E39Q37887560-E473995D-E125-429E-91F8-38E4406D5618Q38030062-5828A7EB-E56E-4189-91F3-D28CFFAB52FBQ38040130-3ECF0172-9F43-4F33-85AC-A7A437CB8131Q38429560-1652763D-0288-4B14-B07D-58301D7C8164
P2860
Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@ast
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@en
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@nl
type
label
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@ast
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@en
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@nl
prefLabel
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@ast
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@en
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@nl
P2093
P2860
P356
P1476
Severe community-acquired pneu ...... c Society Diagnostic criteria.
@en
P2093
Christopher Coley
D Scott Obrosky
Daniel E Singer
Gilles Clermont
Michael J Fine
Thomas J Marrie
Tony T Dremsizov
Wishwa N Kapoor
P2860
P304
P356
10.1164/RCCM.2102084
P407
P577
2002-09-01T00:00:00Z